BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2598467)

  • 1. Analysis of maple syrup urine disease in cell culture: use of substrates.
    Schadewaldt P; Beck K; Wendel U
    Clin Chim Acta; 1989 Sep; 184(1):47-56. PubMed ID: 2598467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maple syrup urine disease: analysis of branched chain ketoacid decarboxylation in cultured fibroblasts.
    Wendel U; Wentrup H; RĂ¼diger HW
    Pediatr Res; 1975 Sep; 9(9):709-17. PubMed ID: 1202420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activities of branched-chain 2-oxo acid dehydrogenase and its components in skin fibroblasts from normal and classical-maple-syrup-urine-disease subjects.
    Chuang DT; Niu WL; Cox RP
    Biochem J; 1981 Oct; 200(1):59-67. PubMed ID: 6895847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of branched-chain amino acids in fibroblasts from patients with maple syrup urine disease and other abnormalities of branched-chain ketoacid dehydrogenase activity.
    Yoshida I; Sweetman L; Nyhan WL
    Pediatr Res; 1986 Feb; 20(2):169-74. PubMed ID: 3080729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiamin-responsive maple-syrup-urine disease: decreased affinity of the mutant branched-chain alpha-keto acid dehydrogenase for alpha-ketoisovalerate and thiamin pyrophosphate.
    Chuang DT; Ku LS; Cox RP
    Proc Natl Acad Sci U S A; 1982 May; 79(10):3300-4. PubMed ID: 6954481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transamination and oxidative decarboxylation rates of branched-chain 2-oxo acids in cultured human skin fibroblasts.
    Schadewaldt P; Radeck W; Hammen HW; Wendel U
    Pediatr Res; 1988 Jan; 23(1):40-4. PubMed ID: 3340442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional differences in the catabolism of branched-chain L-amino acids in cultured normal and maple syrup urine disease fibroblasts.
    Schadewaldt P; Wendel U
    Biochem Med Metab Biol; 1989 Apr; 41(2):105-16. PubMed ID: 2719855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on established lymphoid cells in maple syrup urine disease. Correlation with clinical heterogeneity.
    Jinno Y; Akaboshi I; Katsuki T; Matsuda I
    Hum Genet; 1984; 65(4):358-61. PubMed ID: 6693123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of valine and 3-methyl-2-oxobutanoate by the isolated perfused rat kidney.
    Miller RH; Harper AE
    Biochem J; 1984 Nov; 224(1):109-16. PubMed ID: 6508752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelation between the metabolism of L-isoleucine and L-allo-isoleucine in patients with maple syrup urine disease.
    Wendel U; Langenbeck U; Seakins JW
    Pediatr Res; 1989 Jan; 25(1):11-4. PubMed ID: 2919111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered phosphorylation state of branched-chain 2-oxo acid dehydrogenase in a branched-chain acyltransferase deficient human fibroblast cell line.
    Eisenstein RS; Hoganson G; Miller RH; Harper AE
    J Inherit Metab Dis; 1991; 14(1):37-44. PubMed ID: 1861457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary human fibroblasts from a maple syrup urine disease patient undergo apoptosis following exposure to physiological concentrations of branched chain amino acids.
    Jouvet P; Kozma M; Mehmet H
    Ann N Y Acad Sci; 2000; 926():116-21. PubMed ID: 11193026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme assays with mutant cell lines of maple syrup urine disease.
    Chuang DT; Cox RP
    Methods Enzymol; 1988; 166():135-46. PubMed ID: 3071697
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral L-alloisoleucine loading studies in healthy subjects and in patients with maple syrup urine disease.
    Schadewaldt P; Dalle-Feste C; Langenbeck U; Wendel U
    Pediatr Res; 1991 Nov; 30(5):430-4. PubMed ID: 1754297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of branched-chain 2-oxo acid dehydrogenase activity during exercise.
    Kasperek GJ
    Am J Physiol; 1989 Jan; 256(1 Pt 1):E186-90. PubMed ID: 2912141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of activation of myocardial branched-chain 2-oxo acid dehydrogenase complex in the regulation of leucine decarboxylation during cardiac work in vitro.
    Hildebrandt E; Olson MS
    Biochem J; 1987 Dec; 248(2):423-8. PubMed ID: 3435456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical basis of thiamin-responsive maple syrup urine disease.
    Chuang DT; Ku LS; Cox RP
    Trans Assoc Am Physicians; 1982; 95():196-204. PubMed ID: 7182976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the catabolism of branched-chain L-amino acids in cultured human skin fibroblasts.
    Schadewaldt P; Wendel U
    Pediatr Res; 1987 Nov; 22(5):591-4. PubMed ID: 3684388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute regulation of the branched-chain 2-oxo acid dehydrogenase complex by adrenaline and glucagon in the perfused rat heart.
    Hildebrandt EF; Buxton DB; Olson MS
    Biochem J; 1988 Mar; 250(3):835-41. PubMed ID: 3134009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of thiamin in maple syrup urine disease.
    Elsas LJ; Danner DJ
    Ann N Y Acad Sci; 1982; 378():404-21. PubMed ID: 7044230
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.